日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Pembrolizumab in Patients With Advanced Clear Cell Gynecological Cancer: A Phase 2 Nonrandomized Clinical Trial

帕博利珠单抗治疗晚期透明细胞妇科癌症患者：一项 II 期非随机临床试验

期刊:Jama Oncology
影响因子:20.1
doi:10.1001/jamaoncol.2024.6797
Kristeleit, Rebecca; Devlin, Michael-John; Clamp, Andrew; Gourley, Charlie; Roux, René; Hall, Marcia; Nirsimloo, Rachel; Kounnis, Valentinos; Sage, Lesley; Narayanan, Priya; Herrington, C Simon; Arora, Rupali; Farrelly, Laura; Hughes, Laura; Counsell, Nicholas; Miller, Rowan E
细胞生物学
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Distinct histopathological features are associated with molecular subtypes and outcome in low grade serous ovarian carcinoma

低级别浆液性卵巢癌的不同组织病理学特征与分子亚型和预后相关

期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-023-34627-5
Hollis, Robert L; Thomson, John P; van Baal, Juliette; Ilenkovan, Narthana; Churchman, Michael; van de Vijver, Koen; Dijk, Frederike; Meynert, Alison M; Bartos, Clare; Rye, Tzyvia; Croy, Ian; Diana, Patricia; van Gent, Mignon; Creedon, Helen; Nirsimloo, Rachel; Lok, Christianne; Gourley, Charlie; Herrington, C Simon
肿瘤
肿瘤免疫
卵巢癌
发表日期：2023
文献求助 收藏

Clinicopathological Determinants of Recurrence Risk and Survival in Mucinous Ovarian Carcinoma

黏液性卵巢癌复发风险和生存的临床病理决定因素

期刊:Cancers
影响因子:4.4
doi:10.3390/cancers13225839
Hollis, Robert L; Stillie, Lorna J; Hopkins, Samantha; Bartos, Clare; Churchman, Michael; Rye, Tzyvia; Nussey, Fiona; Fegan, Scott; Nirsimloo, Rachel; Inman, Gareth J; Herrington, C Simon; Gourley, Charlie
卵巢癌
肿瘤
肿瘤免疫
发表日期：2021
文献求助 收藏